Dr Reddys Laboratories (RDY) Cash & Current Investments (2009 - 2026)

Dr Reddys Laboratories has reported Cash & Current Investments for 18 years, with the latest figure at $171.7 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments rose 556.68% year-over-year to $171.7 million in Q2 2026; TTM through Jun 2026 was $171.7 million, a 556.68% increase from a year earlier, with the FY2026 full-year figure at $252.3 million, up 34.9% from the prior year.
• Cash & Current Investments was $171.7 million for Q2 2026 at Dr Reddys Laboratories, down from $243.6 million in the prior quarter.
• The five-year high for Cash & Current Investments was $244.9 million in Q4 2025, with the low at -$1.5 billion in Q3 2024.
• Average Cash & Current Investments over 5 years is -$181.6 million, with a median of $88.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Cash & Current Investments plunged 295.51% in 2022, then soared 556.68% in 2026.
• Over 5 years, Cash & Current Investments stood at -$992.0 million in 2022, then surged by 109.5% to $94.2 million in 2023, then soared by 86.66% to $175.9 million in 2024, then surged by 39.19% to $244.9 million in 2025, then fell by 29.89% to $171.7 million in 2026.
• The last three Cash & Current Investments figures came in at $171.7 million (Q2 2026), $243.6 million (Q1 2026), and $244.9 million (Q4 2025), per Business Quant data.